Lataa...
Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine
SARS‐CoV is a new type of human coronavirus identified as a causative agent of severe acute respiratory syndrome (SARS). On the occasion of the SARS outbreak, various monoclonal antibodies (mAbs) against SARS‐CoV have been developed and applied for diagnosis, clinical management and basic research....
Tallennettuna:
| Julkaisussa: | Rev Med Virol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Ltd.
2006
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7169118/ https://ncbi.nlm.nih.gov/pubmed/16518829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rmv.492 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|